Athenex Moves Forward With $205M New York Plant Post author:Sam Post published:January 11, 2018 Post category:BioPharma According to a SEC filing, the cost of the facility will be paid in part by the State of New York. Source: BioSpace You Might Also Like Dropping Revenue: Expect More Cuts and Closures as LabCorp Aligns Covance Biz April 25, 2017 These 3 Biotechs Could Lead the Next Biotech Boom May 21, 2017 San Diego's Mirati Therapeutics Abandons Lead Drug, Shifts Focus November 14, 2017